|
humans |
42 |
|
female |
29 |
|
male |
29 |
|
middle aged |
26 |
|
adult |
25 |
|
medical sciences |
20 |
|
adolescent |
16 |
|
cross-sectional studies |
14 |
|
aged |
13 |
|
body mass index |
13 |
|
child |
13 |
|
body height |
12 |
|
cohort studies |
12 |
|
elderly |
12 |
|
hepatocellular carcinoma |
12 |
|
hong kong |
12 |
|
survival analysis |
12 |
|
advanced hcc |
10 |
|
advanced hepatocellular carcinoma |
10 |
|
reference values |
10 |
|
sorafenib |
10 |
|
child, preschool |
9 |
|
double-blind method |
9 |
|
adiponectin |
8 |
|
adiponectin - blood |
8 |
|
adverse events |
8 |
|
carcinoma, hepatocellular - mortality - therapy |
8 |
|
chemoembolization, therapeutic - adverse effects - mortality |
8 |
|
child-pugh a |
8 |
|
child-pugh b |
8 |
|
cytology and histology |
8 |
|
hepatitis |
8 |
|
infusions, intra-arterial |
8 |
|
liver neoplasms - mortality - therapy |
8 |
|
oncology medical sciences |
8 |
|
radiology and nuclear medicine pharmacy and pharmacology biology |
8 |
|
transarterial chemoembolization |
8 |
|
body composition - physiology |
7 |
|
down-regulation - physiology |
7 |
|
enzyme-linked immunosorbent assay |
7 |
|
hong kong - epidemiology |
7 |
|
incidence |
7 |
|
intra-abdominal fat - physiopathology |
7 |
|
magnetic resonance imaging |
7 |
|
obstructive sleep apnea |
7 |
|
prevalence |
7 |
|
sleep apnea, obstructive - diagnosis - physiopathology |
7 |
|
subcutaneous fat, abdominal - physiopathology |
7 |
|
sympathetic activity |
7 |
|
sympathetic nervous system - physiopathology |
7 |
|
antipsychotic agents - therapeutic use |
6 |
|
asian continental ancestry group |
6 |
|
bevacizumab |
6 |
|
blood pressure |
6 |
|
body weight |
6 |
|
chemotherapy |
6 |
|
chinese |
6 |
|
dibenzothiazepines - therapeutic use |
6 |
|
erlotinib |
6 |
|
longitudinal studies |
6 |
|
point mutation - genetics |
6 |
|
prospective studies |
6 |
|
psychotic disorders - drug therapy |
6 |
|
risk assessment |
6 |
|
sorafenib-refractory |
6 |
|
alpha-fetoprotein |
5 |
|
carcinoma, hepatocellular - diagnosis - mortality |
5 |
|
china |
5 |
|
clinical trials |
5 |
|
epidemiology |
5 |
|
forced expiratory volume - physiology |
5 |
|
hippo signaling |
5 |
|
infant |
5 |
|
length |
5 |
|
liver neoplasms - diagnosis - mortality |
5 |
|
nuclear proteins - analysis |
5 |
|
outcome |
5 |
|
overall survival |
5 |
|
prediction model |
5 |
|
prognosis |
5 |
|
prognostic marker |
5 |
|
questionnaires |
5 |
|
respiratory diseases |
5 |
|
risk factors |
5 |
|
surrogate |
5 |
|
tace |
5 |
|
time factors |
5 |
|
transcription factors - analysis |
5 |
|
tumor markers, biological - analysis |
5 |
|
tumor recurrence |
5 |
|
yes-associated protein |
5 |
|
young adult |
5 |
|
aged, 80 and over |
4 |
|
aging |
4 |
|
albuminuria - physiopathology |
4 |
|
anxiety - psychology |
4 |
|
audiovisual aids |
4 |
|
beta-thalassemia - physiopathology |
4 |
|
bmi |
4 |
|
breathing exercises |
4 |
|
cardiology - education |
4 |
|
cardiovascular diseases - metabolism - physiopathology |
4 |
|
carrier proteins - genetics |
4 |
|
case-control studies |
4 |
|
catch-up growth |
4 |
|
child development |
4 |
|
children |
4 |
|
cholesterol - blood |
4 |
|
circadian rhythm |
4 |
|
codon - genetics |
4 |
|
comprehension |
4 |
|
continuous positive airway pressure |
4 |
|
depression - psychology |
4 |
|
education, medical, undergraduate |
4 |
|
educational status |
4 |
|
exercise |
4 |
|
exercise therapy |
4 |
|
growth - physiology |
4 |
|
growth curve |
4 |
|
health knowledge, attitudes, practice |
4 |
|
health status |
4 |
|
health surveys |
4 |
|
heart rate |
4 |
|
hpv vaccine |
4 |
|
hpv vaccine perception |
4 |
|
hpv vaccine questionnaire |
4 |
|
hpv vaccine survey |
4 |
|
human papillomavirus |
4 |
|
hypertension - physiopathology - psychology - therapy - urine |
4 |
|
infant, newborn |
4 |
|
insulin - metabolism |
4 |
|
insulin sensitivity |
4 |
|
karyotype |
4 |
|
lupus erythematosus, systemic - epidemiology - genetics |
4 |
|
mannose-binding lectins |
4 |
|
mortality |
4 |
|
nasal continuous positive airway pressure |
4 |
|
obstructive sleep apnoea |
4 |
|
oxygen - metabolism |
4 |
|
papillomaviridae - immunology |
4 |
|
papillomavirus infections - prevention & control - virology |
4 |
|
papillomavirus vaccines |
4 |
|
patient simulation |
4 |
|
pilot projects |
4 |
|
psychiatric status rating scales |
4 |
|
puberty, delayed |
4 |
|
qigong |
4 |
|
quality of life |
4 |
|
randomised controlled trial |
4 |
|
renin - blood |
4 |
|
roc curve |
4 |
|
severity of illness index |
4 |
|
shock - metabolism - physiopathology |
4 |
|
sleep apnea, obstructive - metabolism - therapy |
4 |
|
students, medical |
4 |
|
teaching - methods |
4 |
|
thinness |
4 |
|
treatment outcome |
4 |
|
turner's syndrome |
4 |
|
uterine cervical neoplasms - prevention & control - virology |
4 |
|
weight |
4 |
|
3-month overall survival |
3 |
|
5-ht3 receptor antagonist |
3 |
|
advanced liver cancer prognostic system |
3 |
|
age distribution |
3 |
|
analgesia |
3 |
|
antibodies, bacterial - blood |
3 |
|
antiemetic |
3 |
|
antineoplastic combined chemotherapy protocols - adverse effects - therapeutic use |
3 |
|
area under curve |
3 |
|
bioimpedance |
3 |
|
biological markers - blood |
3 |
|
bone density - physiology |
3 |
|
bone mass density |
3 |
|
bronchiectasis - immunology - microbiology |
3 |
|
c-reactive protein |
3 |
|
c-reactive protein - metabolism |
3 |
|
carboplatin |
3 |
|
carrier proteins - blood |
3 |
|
caucasian |
3 |
|
chi-square distribution |
3 |
|
childhood |
3 |
|
childhood diabetes |
3 |
|
china - ethnology |
3 |
|
chronic obstructive pulmonary disease |
3 |
|
clinical trials. |
3 |
|
development |
3 |
|
dexamethasone |
3 |
|
drugs, chinese herbal - adverse effects - therapeutic use |
3 |
|
dual-energy x-ray absorptiometry |
3 |
|
electric impedance |
3 |
|
european continental ancestry group |
3 |
|
fetal blood - chemistry |
3 |
|
forced expiratory volume |
3 |
|
functional residual capacity |
3 |
|
great britain - epidemiology |
3 |
|
growth |
3 |
|
height |
3 |
|
helicobacter infections - diagnosis - immunology |
3 |
|
helicobacter pylori - immunology - isolation & purification |
3 |
|
hospitalization |
3 |
|
hospitalization - statistics & numerical data |
3 |
|
human growth hormone - blood |
3 |
|
immune function |
3 |
|
infancy |
3 |
|
infant, newborn - physiology |
3 |
|
inflammation |
3 |
|
insulin-like growth factor binding protein 3 - blood |
3 |
|
insulin-like growth factor i - metabolism |
3 |
|
interleukin-6 |
3 |
|
interleukin-8 |
3 |
|
intrauterine growth retardation |
3 |
|
lung disease burden |
3 |
|
lung function |
3 |
|
lung volume measurements |
3 |
|
mannose-binding protein |
3 |
|
maximal expiratory flow rate |
3 |
|
meta-analysis |
3 |
|
metoclopramide |
3 |
|
monotherapy |
3 |
|
mutations |
3 |
|
nchs |
3 |
|
nutritional status |
3 |
|
organ size |
3 |
|
osteoporosis |
3 |
|
osteoporosis - diagnosis - physiopathology |
3 |
|
ovarian cancer |
3 |
|
ovarian neoplasms - drug therapy - immunology |
3 |
|
parecoxib |
3 |
|
plethysmography |
3 |
|
postmenopause - physiology |
3 |
|
postnatal growth |
3 |
|
prematurity |
3 |
|
preterm infants |
3 |
|
prognostic score system |
3 |
|
pulmonary disease, chronic obstructive - blood - physiopathology |
3 |
|
regression analysis |
3 |
|
residual volume |
3 |
|
respiratory tract diseases - epidemiology - mortality |
3 |
|
sex distribution |
3 |
|
smoking - blood |
3 |
|
spirometry |
3 |
|
surgical injury |
3 |
|
total lung capacity |
3 |
|
traditional chinese medicine |
3 |
|
vital capacity |
3 |
|
610.72 s93 |
2 |
|
abstracting, bibliographies, statistics statistics |
2 |
|
acne vulgaris - physiopathology |
2 |
|
administration, intranasal |
2 |
|
aerospace medicine |
2 |
|
age factors |
2 |
|
allergic thiniris |
2 |
|
allergy |
2 |
|
anti-bacterial agents |
2 |
|
anti-inflammatory agents, non-steroidal - administration & dosage - pharmacology |
2 |
|
anti-ulcer agents - diagnostic use - therapeutic use |
2 |
|
anti-ulcer agents - therapeutic use |
2 |
|
antibodies, viral - blood |
2 |
|
anticarcinogenic agents - administration & dosage - pharmacology |
2 |
|
asthma |
2 |
|
asthma - epidemiology |
2 |
|
axilla |
2 |
|
birth weight - physiology |
2 |
|
bismuth - therapeutic use |
2 |
|
blood coagulation |
2 |
|
blood pressure - physiology |
2 |
|
breast - growth & development |
2 |
|
carcinoma |
2 |
|
carcinoma, squamous cell - mortality - pathology - surgery - therapy |
2 |
|
cardia |
2 |
|
catch-down growth posttreatment |
2 |
|
chemicals and cas registry numbers |
2 |
|
chest pain - etiology |
2 |
|
china - epidemiology |
2 |
|
clinical trials -- standards -- china |
2 |
|
congenital heart disease |
2 |
|
cytomegalovirus (cmv) |
2 |
|
cytomegalovirus - genetics - immunology |
2 |
|
data collection |
2 |
|
developing country |
2 |
|
dexmedetomidine - administration and dosage |
2 |
|
diagnostic techniques, digestive system |
2 |
|
disease outbreaks |
2 |
|
disease-free survival |
2 |
|
dissection |
2 |
|
dna, viral - blood |
2 |
|
dnaemia |
2 |
|
dose-response relationship, drug |
2 |
|
drug therapy, combination - therapeutic use |
2 |
|
dyspepsia - drug therapy |
2 |
|
dyspepsia - microbiology |
2 |
|
eczema |
2 |
|
eczema - epidemiology |
2 |
|
ethnic contrast |
2 |
|
ethnicity |
2 |
|
factor v |
2 |
|
factor v - genetics - metabolism |
2 |
|
fetal growth |
2 |
|
final height |
2 |
|
foetal growth retardation |
2 |
|
follow-up studies |
2 |
|
gastroesophageal reflux - complications - diagnosis - drug therapy |
2 |
|
gestational age |
2 |
|
groin |
2 |
|
growth and development |
2 |
|
growth determination |
2 |
|
growth dynamics |
2 |
|
growth evaluation |
2 |
|
growth faltering |
2 |
|
growth hormone |
2 |
|
growth pattern |
2 |
|
growth phase |
2 |
|
h pylori eradication |
2 |
|
hair - growth & development |
2 |
|
helicobacter infections - complications |
2 |
|
helicobacter infections - drug therapy |
2 |
|
helicobacter pylori |
2 |
|
herpesviridae infections - blood - immunology - virology |
2 |
|
herpesvirus 6, human - genetics - immunology |
2 |
|
herpesvirus 7, human - genetics - immunology |
2 |
|
heterozygote |
2 |
|
human herpesvirus 6 (hhv6) and 7 (hhv7) |
2 |
|
hypnotics and sedatives - administration and dosage |
2 |
|
immobilization |
2 |
|
immobilization - physiology |
2 |
|
infant mortality |
2 |
|
infantile diarrhoea |
2 |
|
infants |
2 |
|
intensive care units |
2 |
|
isaac |
2 |
|
kaplan-meier estimate |
2 |
|
kidney transplantation - adverse effects |
2 |
|
knemometry |
2 |
|
leukocytes, mononuclear - immunology - virology |
2 |
|
linear growth |
2 |
|
longitudinal follow-up |
2 |
|
longitudinal study |
2 |
|
lower leg length |
2 |
|
lung - physiology |
2 |
|
maternal smoking |
2 |
|
measuring error |
2 |
|
menarche - physiology |
2 |
|
monitoring, physiologic - methods |
2 |
|
motor development |
2 |
|
neck |
2 |
|
neck dissection - methods |
2 |
|
neonatal mortality |
2 |
|
neoplasm recurrence, local - mortality - pathology |
2 |
|
neoplasm staging |
2 |
|
non-gh deficient |
2 |
|
non-ulcer dyspepsia |
2 |
|
obesity |
2 |
|
observation - methods |
2 |
|
odds ratio |
2 |
|
pakistan |
2 |
|
patient selection |
2 |
|
peptic ulcer - microbiology |
2 |
|
peptic ulcer disease |
2 |
|
peripheral blood leukocytes |
2 |
|
polymerase chain reaction (pcr) |
2 |
|
polymerase chain reaction - methods |
2 |
|
post-campaign |
2 |
|
postneonatal deaths |
2 |
|
postneonatal mortality |
2 |
|
posture |
2 |
|
posture - physiology |
2 |
|
prediction |
2 |
|
pregnancy |
2 |
|
premedication - methods |
2 |
|
prenatal growth |
2 |
|
preschool |
2 |
|
primary teeth emergence |
2 |
|
proportionality |
2 |
|
proton pumps - antagonists & inhibitors |
2 |
|
puberty - physiology |
2 |
|
race |
2 |
|
randomized |
2 |
|
randomized controlled trials as topic |
2 |
|
ranitidine - analogs & derivatives - therapeutic use |
2 |
|
references (31) view in table layout |
2 |
|
renal allograft |
2 |
|
research design |
2 |
|
retrospective studies |
2 |
|
rhinitis |
2 |
|
rhinitis, allergic, perennial - epidemiology |
2 |
|
seasonality |
2 |
|
sensitivity and specificity |
2 |
|
serological responses |
2 |
|
severe acute respiratory syndrome - epidemiology - prevention & control - transmission |
2 |
|
sex characteristics |
2 |
|
sex factors |
2 |
|
short for gestational age |
2 |
|
short stature |
2 |
|
short term |
2 |
|
shortness |
2 |
|
sids |
2 |
|
size at birth |
2 |
|
small for gestational age |
2 |
|
socioeconomic factors |
2 |
|
soft tissue |
2 |
|
stomach neoplasms - epidemiology - microbiology - prevention & control |
2 |
|
sweden |
2 |
|
target height |
2 |
|
temperature |
2 |
|
tongue |
2 |
|
tongue neoplasms - mortality - pathology - surgery - therapy |
2 |
|
tooth, deciduous - growth & development |
2 |
|
transplantation, homologous |
2 |
|
transportation - statistics & numerical data |
2 |
|
travel |
2 |
|
twins |
2 |
|
urban population |
2 |
|
urbanization |
2 |
|
venous thrombosis |
2 |
|
venous thrombosis - epidemiology |
2 |
|
venous thrombosis - genetics |
2 |
|
vital capacity - physiology |
2 |
|
world health |
2 |
|
570.7205 k18 |
1 |
|
acute diarrhoea |
1 |
|
adiposity rebound |
1 |
|
adolescence |
1 |
|
adoption |
1 |
|
adoption - ethnology |
1 |
|
adult overweight |
1 |
|
age at phv |
1 |
|
aging - physiology |
1 |
|
allergens |
1 |
|
anabolic agents - therapeutic use |
1 |
|
analysis of variance |
1 |
|
apgar score |
1 |
|
asphyxia neonatorum - mortality |
1 |
|
benn index |
1 |
|
bilirubin |
1 |
|
birth |
1 |
|
birth defects |
1 |
|
birth length |
1 |
|
birth register |
1 |
|
birth weight |
1 |
|
birthweight |
1 |
|
body height - genetics |
1 |
|
body height - physiology |
1 |
|
body mass index reference values |
1 |
|
box transformation |
1 |
|
breast feeding |
1 |
|
breastfeeding |
1 |
|
case mortality |
1 |
|
cell viability assay |
1 |
|
child care practices |
1 |
|
child development - physiology |
1 |
|
child growth |
1 |
|
childhood onset of growth |
1 |
|
chronic renal failure |
1 |
|
clinical trials - methods |
1 |
|
clinical trials as topic - methods |
1 |
|
coagulability |
1 |
|
community-based |
1 |
|
confidence intervals |
1 |
|
continuing |
1 |
|
crohn's disease |
1 |
|
cytotoxicity |
1 |
|
delayed development |
1 |
|
developing countries |
1 |
|
down's syndrome |
1 |
|
early childhood growth |
1 |
|
education, medical |
1 |
|
education, medical, continuing |
1 |
|
education, medical, graduate |
1 |
|
embryonic and fetal development |
1 |
|
estrogen therapy |
1 |
|
ethnic differences |
1 |
|
feeding patterns |
1 |
|
foetal growth |
1 |
|
gender differences |
1 |
|
gh status |
1 |
|
gh treatment |
1 |
|
growth - genetics |
1 |
|
growth disorders - etiology |
1 |
|
growth hormone - blood - secretion |
1 |
|
growth hormone - therapeutic use |
1 |
|
growth hormone insensitivity |
1 |
|
growth hormone secretion |
1 |
|
growth hormone-binding protein |
1 |
|
growth prediction |
1 |
|
growth rate |
1 |
|
growth references |
1 |
|
growth response |
1 |
|
growth retardation |
1 |
|
growth studies |
1 |
|
growth stunting |
1 |
|
haemodynamic disturbances |
1 |
|
head circumference |
1 |
|
heart defects, congenital - epidemiology - ethnology - surgery |
1 |
|
height growth |
1 |
|
height prediction |
1 |
|
housing standard |
1 |
|
human growth hormone - biosynthesis |
1 |
|
hygiene measures |
1 |
|
icp model |
1 |
|
illiteracy |
1 |
|
inbreeding |
1 |
|
india |
1 |
|
infan cy |
1 |
|
infancy-childhood-puberty (icp) growth model |
1 |
|
infant food |
1 |
|
infant, small for gestational age - metabolism |
1 |
|
infant, small for gestational age - physiology |
1 |
|
inflammatory bowel disease |
1 |
|
insulin-like growth factor i |
1 |
|
insulin-like growth factor-binding protein |
1 |
|
kidney disease |
1 |
|
kidney failure, chronic - complications |
1 |
|
knowledge, attitudes, practice |
1 |
|
labor, obstetric |
1 |
|
legg-calve-perthes' disease |
1 |
|
leptin |
1 |
|
life sciences -- research. |
1 |
|
linear growth retardation |
1 |
|
long term |
1 |
|
longitudinal |
1 |
|
longitudinal growth |
1 |
|
maternal factors |
1 |
|
maternal height |
1 |
|
maternal weight |
1 |
|
medical publishing -- china |
1 |
|
medical publishing -- china. |
1 |
|
medical publishing -- singapore. |
1 |
|
medical publishing -- taiwan. |
1 |
|
medical writing. |
1 |
|
menarche |
1 |
|
menopause |
1 |
|
meta-analyses |
1 |
|
mid-parental height |
1 |
|
mitochondrial function assay |
1 |
|
modified mtt method |
1 |
|
monthly incidence |
1 |
|
morbidity |
1 |
|
neonatal |
1 |
|
nutritional influences |
1 |
|
overweight |
1 |
|
oxandrolone - therapeutic use |
1 |
|
perinatal events |
1 |
|
persistent diarrhoea |
1 |
|
population study |
1 |
|
pre-pubertal height |
1 |
|
precocious puberty |
1 |
|
prediction models |
1 |
|
prepubertal children |
1 |
|
probability |
1 |
|
prospective study |
1 |
|
psychological health |
1 |
|
psychomotor milestones |
1 |
|
puberty |
1 |
|
puberty - blood |
1 |
|
puberty - ethnology |
1 |
|
quality |
1 |
|
questionnaire |
1 |
|
receiver operating characteristics |
1 |
|
reference value |
1 |
|
sars virus |
1 |
|
secular trend |
1 |
|
secular trends |
1 |
|
self-assessment |
1 |
|
severe acute respiratory syndrome - epidemiology - mortality |
1 |
|
short-stature |
1 |
|
side effects |
1 |
|
sitting |
1 |
|
small-for-gestational age |
1 |
|
socio-economic factors |
1 |
|
stature |
1 |
|
stress, psychological - etiology |
1 |
|
study design |
1 |
|
surgical intervention |
1 |
|
sweden - epidemiology |
1 |
|
swedish |
1 |
|
thrombosis |
1 |
|
timing of puberty |
1 |
|
turner syndrome - drug therapy - physiopathology |
1 |
|
ulcerative colitis |
1 |
|
urine |
1 |
|
venous |
1 |
|
well-being |
1 |
